Cortex Pharmaceuticals, Inc. Announces Publication of Research Results on the Use of Ampakines CX1739 and CX717 in the Treatment of Respiratory Disorders
04 mai 2015 09h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., May 4, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company") announces the recent publication of two key scientific papers co-authored by the...
Cortex Pharmaceuticals, Inc. to Present at NewYorkBIO 25th Anniversary Conference
01 mai 2015 09h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., May 1, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly sleep apneas...
Cortex Pharmaceuticals, Inc. Files December 31, 2014 Annual Report on Form 10-K; Provides Update on Current Status and Activities
06 avr. 2015 06h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., April 6, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company") is a leader in developing drugs for respiratory disorders, particularly sleep...
Cortex Pharmaceuticals, Inc. to Present at 7th Annual Biotech Showcase(TM) 2015
09 janv. 2015 08h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., Jan. 9, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly sleep apneas and...
Cortex Pharmaceuticals, Inc. to Participate in 7th Annual Biotech Showcase 2015(TM) Being Held in San Francisco, California From January 12 - 15, 2015
02 déc. 2014 08h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly drug-induced...
Cortex Pharmaceuticals, Inc. Announces Phase 1 Funding by the National Institute of Drug Abuse, National Institutes of Health, Under the Small Business Innovation Research Funding Award Program
24 sept. 2014 08h30 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, including drug-induced...
Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference
04 sept. 2014 18h00 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly...
Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members
04 sept. 2014 17h28 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, including drug-induced...
Cortex Pharmaceuticals, Inc. Enters Into New License Agreement With the University of Illinois Granting Cortex Patent Rights to the Use of Cannabinoids for the Treatment of Sleep Related Breathing Disorders
01 juil. 2014 05h30 HE
|
Cortex Pharmaceuticals, Inc.
GLEN ROCK, N.J., July 1, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a biopharmaceutical company currently engaged in the development of drugs for...